CXCL10 and primary biliary cholangitis: Furthermore, during 8-weeks and 16-weeks periods, IP-10/CXCL10 increased slightly in CXCR3−/− PBC mice without statistical significance compared with WT PBC mice (0.39 ± 0.18 versus 0.28 ± 0.10 at week 8 and 0.46 ± 0.45 versus 0.33 ± 0.19 at week 16).